GLP-Complete: 3-Step System for Natural GLP-1 Pathway Support & Metabolic Balance
3-step daily system supporting GLP-1, gut health, and metabolism. · $119.99 or $101.99/mo
BLOG / Health & Wellness Library
/ Why Stressed Students Blank on Exams They’ve Studied For: The Cortisol-Hippocampus Mechanism, and What the Research on L-Theanine Actually Shows
Short answer. Blanking on an exam you’ve prepared for is a retrieval problem, not a knowledge problem: acute cortisol elevation interferes with the hippocampal processes that let you access stored memories (Gagnon & Wagner, 2016). On L-theanine, the strongest evidence is a 2026 systematic review and meta-analysis of 31 randomized trials, which found that a single 200 mg dose taken 30 to 60 minutes before cognitive testing significantly improved choice reaction time (SMD = 0.51; 95% CI 0.25–0.77), while acute stress effects were modest and anxiety effects inconsistent (Gerolymos et al., 2026). L-Theanine Pro™ delivers that 200 mg dose of AlphaWave® L-Theanine in one capsule daily, with 450 mg of ATA Mg® magnesium acetyl taurate and 2 mg of vitamin B6 as P-5-P. No published trial has measured exam performance with any of it.*
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
You’ve studied 200 hours. You’ve answered this question correctly seventeen times in practice. Your study partners have quizzed you and you’ve gotten it right every time. Then the actual exam begins, and the answer is just gone.
Heart rate spikes. Hands sweat. You move to the next question hoping the blank fills itself in.
That isn’t a preparation failure. It’s neuroscience, and it’s worth understanding before you decide what, if anything, to take.
What the research covers, and what it doesn’t. One randomized, triple-blind, placebo-controlled human trial has been published on AlphaWave® L-Theanine, the branded L-theanine in this formula, at the 200 mg dose used here (Evans et al., 2021). Broader evidence comes from a 2026 systematic review and meta-analysis of 31 randomized trials on L-theanine generally (Gerolymos et al., 2026). No published trial has tested this three-ingredient combination. No published trial has tested magnesium acetyl taurate in humans. No published trial has measured exam performance with any of it. Everything below is written to that standard.
What does the research show about L-theanine for focus and stress during exam periods?
For students dealing with exam-day nerves, the strongest available evidence on L-theanine is a 2026 systematic review and meta-analysis of 31 randomized controlled trials (n = 1,168) published in Molecular Psychiatry. It found that a single 200 mg dose taken 30 to 60 minutes before cognitive testing significantly improved choice reaction time (SMD = 0.51; 95% CI 0.25–0.77), which the authors describe as enhanced attention, and identified this as the most robust finding in the literature. The same review found the acute effect on stress was modest (SMD = 0.31) and leaned on studies at high risk of bias, and that effects on anxiety were inconsistent and not significant.
A separate randomized, triple-blind, placebo-controlled crossover trial on AlphaWave® L-Theanine, the specific branded L-theanine used in this formula, at this exact 200 mg dose, found a significantly greater reduction in salivary cortisol one hour after a timed mental arithmetic stressor versus placebo (p<0.001), and significantly greater frontal alpha power at three hours during the eyes-open portion of the EEG task (p=0.038). L-Theanine Pro™ pairs that 200 mg dose with ATA Mg® magnesium acetyl taurate and active P-5-P in a single daily capsule, as triple-pathway brain support for cognitive flow and calm. It is an over-the-counter dietary supplement, not a controlled substance.*
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
How a Triple-Pathway Formula Is Designed to Support the Body’s Normal Stress Response
One capsule. Three ingredients. One human trial on the branded L-theanine at this dose, plus a meta-analysis of 31 trials on L-theanine generally.
L-Theanine Pro is a neuro-cofactor supplement developed by Triquetra Health for graduate and professional students ages 18 to 30. It’s built for the specific problem of exam-day nerves, blanking despite extensive preparation, and study cycles that work against restorative sleep. Each capsule combines 200 mg of AlphaWave® L-Theanine, a fermentation-derived L-theanine specified by its supplier at ≥98% purity, 450 mg of ATA Mg® magnesium acetyl taurate (magnesium N-acetyltaurinate), and 2 mg of vitamin B6 as P-5-P, 118% of the Daily Value, exactly as declared on the Supplement Facts panel. Vegan, gluten free, soy free, and non-GMO, in a vegetarian HPMC capsule, with rice fiber and diatomaceous earth as the only other ingredients. The on-label positioning is triple-pathway brain support for cognitive flow and calm.
Two human findings anchor the L-theanine layer. Gerolymos et al. (Molecular Psychiatry, 2026) pooled 31 randomized trials (n = 1,168) and found that a single 200 mg dose taken 30 to 60 minutes before cognitive testing significantly improved choice reaction time (SMD = 0.51; 95% CI 0.25–0.77). Evans et al. (Neurology and Therapy, 2021, n=16) ran a randomized, triple-blind, placebo-controlled crossover trial on AlphaWave® L-Theanine and found a significantly greater reduction in salivary cortisol one hour after an acute stress challenge versus placebo (p<0.001), with significantly greater alpha power at three hours.
Both findings deserve their caveats stated up front. The meta-analysis covers L-theanine as an ingredient class, not this branded source. It also found that cognitive benefits showed up within roughly two hours of dosing and that studies testing beyond that window generally came back negative. A separate systematic review and meta-analysis of five randomized trials in 148 healthy adults found a significant dose-dependent improvement in rapid visual information processing and recognition visual reaction time, but no significant effect on simple reaction time or Stroop performance, and concluded that L-theanine’s cognitive benefits could not be confirmed across all test methods (Mátyus et al., 2025). The Evans trial was funded by the ingredient supplier and enrolled 16 adults.
One capsule daily. The 30-count bottle is a one-month supply at that serving.*
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
You Haven’t Failed Your Preparation
Medical school. Law school. Graduate programs. You chose an exceptionally demanding path, and you’ve shown up for it: 6 AM study sessions, 200-page case packets, practice exams run until the methodology becomes instinct.
Then the real exam arrives. And classmates who seem to study fewer hours walk out with better scores.
You already know the backdrop. Non-prescription stimulant use is real on graduate and professional campuses, though the numbers swing widely depending on who’s counting and how. A 2022 narrative review in Psychiatry International puts lifetime nonmedical prescription stimulant use among college students somewhere between 5% and 35%, and reports rates among medical students ranging from 5.2% to 47.4% across institutions, with the high end coming from a single-institution survey rather than a national estimate (Edinoff et al., 2022). Academic enhancement is the most commonly cited reason. The pressure that creates isn’t subtle, even if the real prevalence in your cohort is lower than hallway conversation suggests.
Here’s the part nobody mentions. The academic payoff isn’t what students assume. Arria et al. (Addictive Behaviors, 2017) followed 898 college students and found that nonmedical stimulant use was not associated with improved grades; GPA gains were significantly greater among students who didn’t use them.
And you’ve tried to close the gap honestly. Generic L-theanine off Amazon. A meditation app downloaded during finals week and abandoned by Wednesday. None of it reliably changed the one thing that decides test day, which is whether the material is there when you reach for it.
So let’s be clear about what’s actually happening. Blanking under exam pressure isn’t a knowledge deficit. It isn’t evidence that you’re fundamentally less capable than the people sitting around you.
Stress neuroscience has documented the mechanism for decades. Acute cortisol elevation interferes with hippocampal memory retrieval (Gagnon & Wagner, Annals of the New York Academy of Sciences, 2016). Information that was encoded and stored successfully during your study sessions becomes temporarily harder to access, because cortisol disrupts the retrieval process itself. The knowledge is there. The path to it is crowded.
Late nights compound the problem from a different direction, because the sleep you trade away is the sleep that consolidates study material into long-term memory.
Why do I blank on exams even when I’ve studied the material?
Blanking despite extensive preparation isn’t a knowledge problem. Acute cortisol elevation interferes with hippocampal memory retrieval: the stress hormone disrupts the pathways that allow access to memorized information even when encoding and storage were successful during study sessions (Gagnon & Wagner, 2016). This is well established in stress neuroscience, and it helps explain why students who ace practice exams under relaxed conditions come up empty on identical material under performance pressure. L-Theanine Pro™ is formulated around this mechanism, though no study has measured exam recall with it. What has been measured: in a randomized, triple-blind, placebo-controlled crossover trial, a single 200 mg dose of AlphaWave® L-Theanine produced a significantly greater reduction in salivary cortisol one hour after a timed mental arithmetic stressor than placebo (p<0.001), and significantly greater alpha power at three hours (p=0.038 frontal, p=0.050 whole-scalp, eyes-open condition). In a 2026 meta-analysis of 31 randomized trials, a single 200 mg dose taken 30 to 60 minutes before cognitive testing improved choice reaction time (SMD = 0.51). The three-ingredient combination in this formula has not itself been studied.*
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Why Generic L-Theanine Often Disappoints
Generic L-theanine is an accessible entry point, but sourcing and stereoisomeric purity vary between manufacturers, and many products disclose neither. L-theanine is the biologically active isomer, and the manufacturing method determines how much of what’s in the bottle actually is L-theanine.
Ours is AlphaWave® L-Theanine, specified by its supplier as fermentation-derived at ≥98% purity. We publish the per-capsule dose, and it is the same branded material tested in the Evans 2021 trial at the 200 mg dose used here. Check the label of whatever you’re comparing for the same two things: purity specification and sourcing method.
Generic single-ingredient products also contain no brain-delivered magnesium form and no P-5-P cofactor, so two of the three layers in this formula go unaddressed.
A note on prescription medications. L-Theanine Pro is a dietary supplement. It is not a substitute for any prescription medication, and nothing in this guide should be read as a comparison of its effects to those of a prescription drug. If you are considering or currently taking a prescription medication for focus, attention, sleep, or stress, that decision belongs with your healthcare provider.
How the Three Ingredients Work at Three Different Points in the Stress-Response Pathway
Layer 1: AlphaWave® L-Theanine, 200 mg
When you sit down to a high-stakes exam, your HPA axis (the hypothalamic-pituitary-adrenal stress circuit) activates and releases cortisol. In the hippocampus, the brain region responsible for memory retrieval, cortisol binds glucocorticoid receptors and disrupts the processes that let you access stored information (Gagnon & Wagner, 2016). That’s the documented neurobiology behind blanking: the information was successfully encoded, but retrieval runs into interference.
The receptor-level mechanism for L-theanine is not settled, and you should know that before you read further. In an in vitro radioligand binding assay using rat brain membranes, theanine bound with low affinity at AMPA, kainate, and glycine-site NMDA targets (Kakuda et al., 2002). A later characterization described L-theanine as a partial co-agonist with excitatory action at NMDA receptors in cultured hippocampal neurons (Sebih et al., 2017), which points in the opposite direction. Both are cell and tissue studies. Whether either translates into a meaningful effect on HPA-axis signaling in humans has not been established.
What has been measured in humans is narrower and more useful. In the Evans 2021 trial at this exact 200 mg dose, participants showed a significantly greater reduction in salivary cortisol one hour post-dose versus placebo (p<0.001). Average within-group declines were 42.4% on L-theanine and 32.6% on placebo. Part of the decline in both arms reflects the normal diurnal cortisol curve, so the real effect is the gap between the two, not the raw number. Frontal alpha power was significantly greater than placebo at three hours during the eyes-open portion of the EEG task (p=0.038), with whole-scalp alpha power also significantly greater during that same portion (p=0.050). That trial defined the alpha band as 8 to 12 Hz. Midline theta showed no significant change.
Two results from that trial that cut the other way: post-dose self-reported state anxiety and stress did not differ significantly between groups, and one participant showed elevated AST and ALT liver enzymes between screening and day 8, which investigators classified as unlikely to be related to the product.
Layer 2: ATA Mg® Magnesium Acetyl Taurate, 450 mg per capsule
The physical side of exam-day nerves involves excitatory signaling, and magnesium plays a regulatory role in it. Magnesium provides voltage-dependent block of NMDA receptor channels (Nowak et al., Nature, 1984). Delivery to brain tissue is the harder part, because standard magnesium forms are hydrophilic and the blood-brain barrier restricts their entry.
Per the supplier’s technical dossier, N-acetylation of the taurate molecule increases lipophilicity and eases membrane passage. Treat that as a proposed mechanism rather than a confirmed one.
Uysal et al. (Biological Trace Element Research, 2019) gave five magnesium forms as a single oral dose equivalent to 400 mg per 70 kg to Sprague Dawley rats, seven animals per group: sulfate, oxide, acetyl taurate, citrate, and malate. Magnesium acetyl taurate was rapidly absorbed, crossed into the brain readily, produced the highest brain tissue magnesium concentration of the five forms tested, and was associated with reduced anxiety indicators in behavioral testing. Magnesium malate followed closely for brain concentration and had the highest area under the curve, with acetyl taurate second. Magnesium oxide and citrate showed the lowest bioavailability. Magnesium glycinate was not among the forms tested.
This is animal data. Comparable human pharmacokinetic studies on magnesium acetyl taurate have not been published, so treat the brain-delivery rationale as preclinical and unconfirmed in people.
Layer 3: The Coenzyme Form of Vitamin B6 (P-5-P, 2 mg)
Pyridoxal-5’-phosphate is the active coenzyme form of vitamin B6 and the required cofactor for glutamic acid decarboxylase (GAD), the rate-limiting enzyme converting glutamate into GABA. Without adequate cofactor, that conversion runs below capacity. Unlike pyridoxine HCl, P-5-P requires no hepatic conversion and is immediately available for enzyme binding.
On magnesium and B6 together, the evidence deserves a careful read. Pouteau et al. (PLOS ONE, 2018, n=264) compared magnesium plus vitamin B6 against magnesium alone in stressed adults with low serum magnesium. Across the overall population, both arms reduced DASS-42 stress scores substantially (44.9% and 42.4%) with no statistically significant difference between them, and the authors concluded that adding B6 was not superior to magnesium alone. In a pre-specified subgroup with severe or extremely severe stress (n=162), the combination produced a 24% greater improvement at Week 8 (p=0.0203).
Three limitations you should weigh. That trial was single-blind (investigator-blinded) rather than double-blind. It used 300 mg of magnesium per day, substantially more magnesium than this formula’s magnesium ingredient provides. And it used 30 mg of pyridoxine hydrochloride rather than P-5-P, in adults with low magnesemia. It supports the rationale for pairing the two nutrients. It does not validate this formula’s dose or form.
Each capsule declares 2 mg of vitamin B6 as P-5-P, 118% of the Daily Value. That is the figure printed on the panel. For context, the European Food Safety Authority set a tolerable upper intake level of 12 mg per day in 2023, and the U.S. National Institutes of Health lists a tolerable upper intake level of 100 mg per day for adults, so the amount here sits far below both.*
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
What the Research Means for Your Exam Days, Study Sessions, and Sleep
Attention and Reaction Time
The most robust finding in the L-theanine literature is an acute one. Pooling 31 randomized trials, Gerolymos et al. (2026) found that a single 200 mg dose taken 30 to 60 minutes before cognitive testing significantly improved choice reaction time (SMD = 0.51; 95% CI 0.25–0.77). The benefit appeared within roughly two hours of dosing, consistent with L-theanine’s short half-life, and trials that tested cognition after that window generally came back negative.
Two things temper it. The review pools generic L-theanine across ingredient sources, not this branded material specifically. And a separate meta-analysis of five randomized trials in 148 healthy adults found the picture is domain-specific: a significant dose-dependent improvement in rapid visual information processing and recognition visual reaction time, but no significant effect on simple reaction time or on the Stroop test, with the authors concluding that L-theanine’s cognitive benefits could not be confirmed across all test methods (Mátyus et al., 2025).
That’s the honest ceiling: a well-supported acute attention effect in a mixed literature, at exactly the dose and timing this product uses.
Cortisol Under Acute Stress
Evans et al. 2021 measured salivary cortisol under triple-blind crossover conditions during a timed mental arithmetic stressor, which makes it the most exam-analogous published evidence on this ingredient. Participants took the dose, faced a timed stress task 45 minutes later, and showed significantly greater cortisol reduction than on placebo at one hour (p<0.001).
Read the boundary carefully. That trial measured cortisol and brain wave activity under stress. It did not measure exam scores, recall, or test performance, and neither has any other trial on this ingredient. The 2026 meta-analysis also found that L-theanine’s acute effect on stress across the wider literature was modest (SMD = 0.31) and driven substantially by studies at high risk of bias.
One further boundary worth stating plainly, since this article is built on cortisol: in a four-week trial using a different branded L-theanine at 200 mg daily, four weeks of administration had no significant effect on cortisol levels in saliva or serum (Hidese et al., 2019). The cortisol finding here comes from acute single-dose testing, not from daily use over weeks.
Verbal Fluency and Executive Function
Hidese et al. (Nutrients, 2019) ran a four-week randomized, double-blind, placebo-controlled crossover trial in 30 healthy adults (mean age 48.3, range 20 to 69) with no major psychiatric illness, dosing 200 mg nightly. Verbal fluency and executive function scores improved significantly after L-theanine administration (p=0.001 and p=0.031), while no significant change occurred after placebo. Sleep quality scores also improved within-group (p=0.013).
Four qualifications, all of which matter.
That trial used a different branded L-theanine, supplied by Taiyo Kagaku, not the AlphaWave® ingredient in this formula. We cite it as evidence about L-theanine generally, never as evidence about this product’s specific ingredient source.
When score changes were compared directly between the L-theanine and placebo periods, no cognitive measure reached significance. The between-group advantage in verbal fluency appeared only in the half of participants with lower baseline scores (p=0.002, n=15).
Within-group improvements in stress-related questionnaire scores likewise did not reach significance when compared directly against placebo.
And the trial was funded by the ingredient supplier, with two co-authors employed by that company.
Verbal reasoning, analytical thinking, and executive processing are the kinds of cognitive work that separate outcomes between equally prepared candidates. That’s why the trial is relevant. The qualifications are why it isn’t proof.
Winding Down After Late-Night Studying
Memory consolidation, the process that converts studied material into durable long-term memory, happens largely during sleep. The night before an exam is the most neurologically valuable sleep opportunity in your preparation timeline, and it’s also the night most likely to be wrecked by nerves.
In the Hidese 2019 trial, with 200 mg taken nightly for four weeks, overall sleep quality scores improved within-group (p=0.013), and the sleep latency and sleep disturbance subscales improved significantly more than placebo (p=0.0499 and p=0.046). Total sleep quality score did not reach significance in the between-group comparison (p=0.073). Again, that trial used a different branded L-theanine source.
If you take your single daily capsule in the evening rather than the morning, that’s the relevant research. Some students prefer it that way. Take one capsule per day either way, not both.*
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
When should I take L-theanine before an exam, and how much?
One capsule, 60 to 90 minutes before your exam begins, at 200 mg. That timing comes from two findings. The 2026 systematic review and meta-analysis of 31 randomized trials (n = 1,168) in Molecular Psychiatry found that choice reaction time improved with a single 200 mg dose taken 30 to 60 minutes before cognitive testing (SMD = 0.51; 95% CI 0.25–0.77), with benefits concentrated within roughly two hours of dosing and trials testing beyond that window generally returning negative results (Gerolymos et al., 2026). The randomized, triple-blind, placebo-controlled crossover trial on AlphaWave® L-Theanine measured a significantly greater salivary cortisol reduction than placebo one hour after a single 200 mg dose during a timed mental arithmetic stressor (p<0.001), with significantly greater EEG alpha power at three hours (Evans et al., 2021).
For multi-day exams such as the bar exam or USMLE Step formats, take one capsule 60 to 90 minutes before each day’s start. L-Theanine Pro™ is one capsule daily, and we make no claim that extended daily use produces additional or cumulative benefit, because the published research on this branded ingredient is acute single-dose research. It is an over-the-counter dietary supplement, not a substitute for any prescription medication, and no published trial has measured exam performance with it. Consult your healthcare provider before use if you take prescription medications.*
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
The Published Research Behind the Ingredients
Every study named below is peer-reviewed, and each is verifiable through the DOI and, where indexed, the PubMed identifier given in the reference list. Verify them before you buy, and read the limitations sections. The details matter more than the abstracts suggest.
Gerolymos et al. 2026: Systematic Review and Meta-Analysis of 31 Randomized Trials
Design: Systematic review and meta-analysis of 31 randomized controlled trials comparing oral L-theanine with placebo in healthy and clinical populations, n = 1,168
Key findings: A single 200 mg dose taken 30 to 60 minutes before cognitive testing significantly improved choice reaction time (SMD = 0.51; 95% CI 0.25–0.77), indicating enhanced attention. The authors describe this as the most robust finding in the literature and note it as a short-term benefit in healthy adults. L-theanine was assessed as safe on dropout rates and reasons.
Limitations to know: Acute stress reduction was modest (SMD = 0.31) and leaned on studies at high risk of bias. Anxiety effects were inconsistent and not significant. Cognitive benefits appeared within roughly two hours of dosing; trials testing beyond that window generally returned negative results. The review covers L-theanine as an ingredient class, not any specific branded source. The senior author declares having founded a company that sells dietary supplements.
Citation: Gerolymos C, Saddier E, Boyer L, Fond G. (2026). Molecular Psychiatry, advance online publication. DOI: 10.1038/s41380-026-03727-9. PMID: 42410082.
Mátyus et al. 2025: Systematic Review and Meta-Analysis of Five Randomized Trials
Design: Systematic review and meta-analysis of five randomized, placebo-controlled trials of L-theanine on cognitive performance, n = 148 healthy adults
Key findings: A significant dose-dependent effect on rapid visual information processing and recognition visual reaction time (mean difference −15.20 ms; 95% CI −28.99 to −1.41).
Limitations to know: No significant effect on reaction time to a simple stimulus (mean difference −0.46 ms; 95% CI −15.65 to 14.73) or on the Stroop test (mean difference −37.38 ms; 95% CI −86.39 to 11.62). The authors conclude that L-theanine’s beneficial effects on cognitive performance could not be confirmed by all test methods, attribute the contradictory results partly to L-theanine affecting only certain cognitive domains and partly to the small number of trials and heterogeneity of the test preparations, and call for further trials using standardized products with larger samples. We include it because it is the counterweight to the larger meta-analysis.
Citation: Mátyus RO, Szikora Z, Bodó D, Vargáné Szabó B, Csupor É, Csupor D, Tóth B. (2025). Journal of Clinical Medicine, 14(21), 7710. DOI: 10.3390/jcm14217710. PMID: 41227106.
Evans et al. 2021: Cortisol and Alpha Power During Acute Stress (AlphaWave® L-Theanine)
Design: Randomized, triple-blind, placebo-controlled crossover with 7-day washout
Intervention: Single 200 mg dose of AlphaWave® L-Theanine, the branded L-theanine used in this formula, or placebo
Population: n=16 adults aged 19 to 60 with moderate stress (Perceived Stress Scale 14–26); one participant withdrew after period 1
Stressor: 10-minute mental arithmetic test under timed, paced pressure
Key findings: Significantly greater decrease in salivary cortisol at 1 hour post-dose versus placebo (p<0.001); average within-group declines were 42.4% with L-theanine and 32.6% with placebo. Frontal alpha power significantly greater than placebo at 3 hours during eyes-open recording (p=0.038); whole-scalp alpha power significantly greater during the same portion (p=0.050). Alpha band defined as 8 to 12 Hz. No midline theta change.
Limitations to know: Small sample. Post-dose self-reported state anxiety and stress showed no significant between- or within-group differences. Both arms showed cortisol decline consistent with the normal diurnal curve; the L-theanine effect is the difference between arms. One participant showed elevated AST and ALT liver enzymes between screening and day 8, classified by investigators as unlikely to be related to the product. Funded by the ingredient supplier.
Citation: Evans M, McDonald AC, Xiong L, Crowley DC, Guthrie N. (2021). Neurology and Therapy, 10(2), 1061–1078. DOI: 10.1007/s40120-021-00284-x. PMID: 34562208.
Hidese et al. 2019: Cognitive and Sleep Outcomes (Different Branded L-Theanine)
Design: Randomized, placebo-controlled, double-blind crossover trial; 200 mg daily taken before sleep, four weeks per arm with a two-week washout
Population: n=30 (9 men, 21 women), mean age 48.3 ± 11.9 years (range 20–69), healthy adults without major psychiatric illness
Ingredient: A different branded L-theanine, supplied by Taiyo Kagaku Co., Ltd., not the AlphaWave® source used in this formula
Key findings: Verbal fluency improved (p=0.001) and executive function improved (p=0.031) after L-theanine but not placebo. Sleep quality improved within-group (p=0.013), with the sleep latency and sleep disturbance subscales improving significantly more than placebo (p=0.0499 and p=0.046). No participant drop-out (100% compliance); no adverse events observed.
Limitations to know: Different branded ingredient source. Four weeks of administration had no significant effect on cortisol in saliva or serum. Between-group comparison of cognitive score changes found no significant difference on any measure; verbal fluency significance versus placebo emerged only in the lower-baseline half of participants (p=0.002, n=15). Within-group improvements on stress-related questionnaires did not reach significance against placebo. Total sleep quality score between-group comparison was not significant (p=0.073). Funded by the L-theanine supplier; two co-authors were employees of that company. Participants were middle-aged on average, not students.
Citation: Hidese S, Ogawa S, Ota M, et al. (2019). Nutrients, 11(10), 2362. DOI: 10.3390/nu11102362. PMID: 31623400.
Kimura et al. 2007: Acute Stress Response to a Mental Arithmetic Task
Design: Double-blind, placebo-controlled crossover, four separate trials per participant
Intervention: 200 mg L-theanine, taken either at the start of the procedure or midway
Population: n=12
Key findings: L-theanine was associated with reduced heart rate and reduced salivary immunoglobulin A responses to the acute stressor, alongside reductions in subjective stress.
Limitations to know: Very small sample. Two co-authors were affiliated with Taiyo Kagaku Co., Ltd., the same L-theanine supplier that funded Hidese et al., so this is not an independent replication. Uses the same mental arithmetic stress paradigm as Evans et al., which is why it’s included.
Citation: Kimura K, Ozeki M, Juneja LR, Ohira H. (2007). Biological Psychology, 74(1), 39–45. DOI: 10.1016/j.biopsycho.2006.06.006. PMID: 16930802.
Pouteau et al. 2018: Magnesium With and Without Vitamin B6 in Stressed Adults
Design: Phase IV randomized, single-blind (investigator-blinded) clinical trial over 8 weeks; magnesium plus vitamin B6 versus magnesium alone
Population: n=264 healthy adults with severe or extremely severe stress and low serum magnesium
Key findings: In a pre-specified subgroup with severe or extremely severe stress (n=162), the magnesium plus B6 combination produced a 24% greater improvement in DASS-42 stress score at Week 8 than magnesium alone (p=0.0203).
Limitations to know: Across the overall population, both arms reduced DASS-42 stress scores substantially (44.9% and 42.4%) with no statistically significant difference between them, and the authors concluded that adding B6 was not superior to magnesium alone overall. Single-blind design. Used 300 mg of magnesium per day, substantially more magnesium than this formula’s magnesium ingredient provides, and 30 mg of pyridoxine hydrochloride rather than P-5-P. Enrolled adults with low magnesemia. It supports the rationale for pairing the two nutrients; it does not validate this formula’s dose or form.
Citation: Pouteau E, Kabir-Ahmadi M, Noah L, et al. (2018). PLOS ONE, 13(12), e0208454. DOI: 10.1371/journal.pone.0208454. PMID: 30562392.
Uysal et al. 2019: Comparative Brain Magnesium (Animal Study)
Design: Comparative single-dose bioavailability analysis in Sprague Dawley rats, seven animals per group, at a dose equivalent to 400 mg per 70 kg, across five magnesium forms: sulfate, oxide, acetyl taurate, citrate, malate
Key finding: Magnesium acetyl taurate was rapidly absorbed, crossed into the brain readily, produced the highest brain tissue concentration of the five forms tested, and was associated with reduced anxiety indicators in behavioral testing. Magnesium malate followed closely for brain concentration and had the highest area under the curve, with acetyl taurate second. Oxide and citrate showed the lowest bioavailability.
Limitations to know: Rodent study with small group sizes and a single dose, not human pharmacokinetics. Magnesium glycinate was not tested. The authors called for further research. No human pharmacokinetic trial on magnesium acetyl taurate has been published.
Citation: Uysal N, Kizildag S, Yuce Z, et al. (2019). Biological Trace Element Research, 187(1), 128–136. DOI: 10.1007/s12011-018-1351-9. PMID: 29679349.
Regulatory Status
According to the supplier, AlphaWave® L-Theanine was accepted into Australia’s Permissible Ingredients Determination in 2024 following an 18-month submission covering manufacturing systems, analytical methods, and safety and quality data. Listed medicines are Australia’s lower-risk regulatory pathway, and the Therapeutic Goods Administration does not conduct pre-market efficacy review for that category. Treat it as a quality and safety credential, not an efficacy approval.
L-theanine is the subject of multiple Generally Recognized as Safe (GRAS) notices for use in specified conventional food categories, to which the U.S. Food and Drug Administration responded that it had no questions (GRN 209, 338, 501). GRAS status concerns conventional food use and is separate from the dietary-supplement ingredient pathway.
Magnesium acetyl taurate was the subject of a 2009 European Food Safety Authority safety assessment of taurate magnesium sources. That is an assessment, not an EU authorization; magnesium acetyl taurate is not on the EU positive list of permitted mineral sources for food supplements. In the United States, a New Dietary Ingredient notification for this magnesium form is on FDA’s public list (NDIN #1139, ATA-Mg®, notifier AIDP Inc., filed January 2020). An NDI notification is a premarket safety notification, not FDA approval.
What is L-Theanine Pro and what research is behind it?
L-Theanine Pro™ is a neuro-cofactor supplement developed by Triquetra Health for graduate and professional students dealing with exam-day nerves and study cycles that work against sleep. One capsule daily delivers 200 mg of AlphaWave® L-Theanine, a fermentation-derived L-theanine specified at ≥98% purity, 450 mg of ATA Mg® magnesium acetyl taurate, and 2 mg of vitamin B6 as P-5-P at 118% of the Daily Value. The published research: a 2026 systematic review and meta-analysis of 31 randomized trials (n = 1,168) found that a single 200 mg dose taken 30 to 60 minutes before cognitive testing significantly improved choice reaction time (SMD = 0.51; 95% CI 0.25–0.77), while finding acute stress effects modest and anxiety effects inconsistent (Gerolymos et al., 2026, Molecular Psychiatry, PMID: 42410082).
A randomized, triple-blind, placebo-controlled crossover trial on AlphaWave® L-Theanine found a significantly greater salivary cortisol reduction one hour after a timed stressor than placebo (p<0.001) and significantly greater alpha power at three hours (Evans et al., 2021, PMID: 34562208). A four-week trial using a different branded L-theanine at 200 mg daily reported improved verbal fluency and executive function scores within-group, with no significant between-group cognitive difference and no effect on cortisol (Hidese et al., 2019, PMID: 31623400). At one capsule daily, the 30-count bottle is a one-month supply; a 60-count bottle of the identical formula is also available. No published trial has tested the three-ingredient combination, tested magnesium acetyl taurate in humans, or measured exam performance.*
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
A Reference Table for Students Comparing Their Options
This table describes what different approaches do and do not do, based on published research. It is not a recommendation to substitute a dietary supplement for any medication, and it is not medical advice.
What should students look for in a study-support supplement?
Three things separate a defensible supplement choice from a marketing one. First, a disclosed dose you can match against published research, rather than a proprietary blend that hides how much of anything you’re getting. Second, evidence at the dose and timing you’ll actually use it, which for L-theanine means acute single-dose research at 200 mg taken shortly before the task, since the 2026 meta-analysis of 31 trials found benefits concentrated within about two hours of dosing.
Third, honest limitations from the brand itself. L-Theanine Pro delivers 200 mg of AlphaWave® L-Theanine per capsule, one capsule daily, and the published research on it is a single randomized triple-blind crossover trial measuring cortisol and EEG alpha power under acute stress, supported by meta-analytic evidence on L-theanine as an ingredient class. Worth knowing before you compare it to anything else: research on 898 college students found nonmedical stimulant use was not associated with improved grades (Arria et al., 2017). L-Theanine Pro™ is an over-the-counter dietary supplement, not a substitute for any prescription medication, and no trial has measured exam performance with it.*
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Your Questions, Answered
How is this different from the generic L-theanine I already tried?
Three things. Ours is AlphaWave® L-Theanine, fermentation-derived and specified at ≥98% purity, which many inexpensive products don’t disclose at all. It’s the same branded material tested in the Evans 2021 trial, at the 200 mg dose in each capsule, so you can match the label against a specific published study. And the formula adds two layers generic single-ingredient products don’t have: ATA Mg® magnesium acetyl taurate and P-5-P. The magnesium rationale rests on animal data, which we say plainly rather than implying human evidence exists.
How many capsules should I take?
One capsule per day. Not two, and not one in the morning plus one at night. The label’s suggested use is one capsule daily with water, with or without a meal. If you’d rather take your single daily capsule in the evening, the four-week sleep research at 200 mg nightly is the relevant evidence, with the caveats noted above.
Will it make me drowsy while I’m studying?
The research points the other way. In the Evans 2021 trial, EEG alpha power in the 8 to 12 Hz band was significantly greater than placebo while participants were doing timed arithmetic under pressure, not resting. And the strongest pooled finding in the 2026 meta-analysis of 31 randomized trials was faster choice reaction time, which is not what sedation looks like. No trial on this ingredient has measured sedation as an endpoint.
How long does one bottle last?
At one capsule daily, the 30-count bottle is a one-month supply, which covers a single exam block. A 60-count bottle of the identical formula at the identical one-capsule serving is also available if you would rather cover a longer stretch in one order. We don’t claim additional benefits accrue from longer use, because the published research on this branded ingredient is acute single-dose research.
Can I take it if I’m on a prescription medication?
Ask your healthcare provider first, particularly if you take anxiolytics, antidepressants, or ADHD medications. L-Theanine Pro™ is a dietary supplement, not a substitute for any prescription medication, and we don’t make claims about combining it with one.*
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
How do I wind down after late-night studying?
For students who struggle to shift from a late study session into sleep, the relevant research on L-theanine is a four-week randomized, double-blind, placebo-controlled crossover trial at 200 mg taken nightly. Overall sleep quality scores improved within-group (p=0.013), and the sleep latency and sleep disturbance subscales improved significantly more than placebo (p=0.0499 and p=0.046), though the total sleep quality score did not reach between-group significance (p=0.073) (Hidese et al., 2019).
That trial used a different branded L-theanine source than this formula, which is why we present it as evidence about the ingredient rather than about this product, and its participants were middle-aged on average rather than students. Sleep is not downtime from studying; it’s the active process where daytime material consolidates into long-term memory, which is why the night before an exam matters neurologically. L-Theanine Pro is one capsule daily. Students who want the evening timing simply take their single daily capsule at night instead of in the morning. Four weeks of daily L-theanine had no significant effect on cortisol in saliva or serum in that same trial.*
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Choose Your Bottle
L-Theanine Pro™ is a neuro-cofactor formula for students dealing with exam-day nerves and the study cycles that work against sleep. One capsule daily.
One randomized, triple-blind, placebo-controlled human trial on AlphaWave® L-Theanine at the 200 mg dose used here. Meta-analytic evidence across 31 randomized trials on L-theanine at the same dose and timing. Over-the-counter and not a controlled substance. A 60-day satisfaction guarantee (see guarantee terms).
The 30-Count Bottle
Thirty capsules at one capsule daily, which the Supplement Facts panel declares as 30 servings per container: a one-month supply, enough to carry a single exam block. The label’s suggested use is one capsule daily with water, with or without a meal. Take it 60 to 90 minutes before study sessions or your exam.
[Shop the 30-Count →
A 60-count bottle of the identical formula at the identical one-capsule serving is also available if you want to cover a longer stretch in one order. We don’t claim added benefit from longer use, because the research on this ingredient is acute single-dose research. [Shop the 60-Count →
Vegan, gluten free, soy free, and non-GMO, in a vegetarian HPMC capsule, with rice fiber and diatomaceous earth as the only other ingredients. Manufactured in a facility operating under current Good Manufacturing Practices, third-party tested, with certificates of analysis available on request. Current pricing is shown on each product page.*
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
How long does one bottle of L-Theanine Pro last, and which size should I get?
The 30-count bottle is a one-month supply at one capsule daily, and a 60-count bottle is available for a longer stretch. Both hold the identical formula at the identical serving: one capsule daily, delivering 200 mg of AlphaWave® L-Theanine, 450 mg of ATA Mg® magnesium acetyl taurate, and 2 mg of vitamin B6 as P-5-P at 118% of the Daily Value. The choice is about how long you want the supply to last, not about a different protocol.
For either bottle, the usage grounded in published research is a single 200 mg dose taken shortly before the task: the 2026 systematic review and meta-analysis of 31 randomized trials found choice reaction time improved with a single 200 mg dose taken 30 to 60 minutes before cognitive testing (Gerolymos et al., 2026), and the Evans 2021 trial on AlphaWave® L-Theanine measured cortisol reduction one hour after a single 200 mg dose during a timed stressor. We make no claim that extended daily use produces additional or cumulative benefit, because the published research on this branded ingredient is acute single-dose research.*
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
For the Research-Literate Student: Technical Documentation
Written for pre-med, pharmacy, and research-track students who read primary literature as a matter of habit.
Full Ingredient Technical Profile
AlphaWave® L-Theanine (200 mg per capsule)
Molecular identity and pharmacokinetics. L-γ-glutamylethylamide, structurally similar to L-glutamic acid. Human disposition studies report an elimination half-life of roughly 58 to 74 minutes, measured at doses of 25 to 100 mg (van der Pijl et al., 2010), which is below the 200 mg dose used here. The 2026 meta-analysis notes that cognitive benefits appear within approximately two hours of dosing, consistent with that half-life, and that trials testing beyond that window generally returned negative results.
Receptor-level mechanism, unsettled. In an in vitro radioligand binding assay using rat brain membranes, theanine bound with low affinity at AMPA, kainate, and glycine-site NMDA targets (Kakuda et al., 2002). A later characterization in cultured hippocampal neurons and Xenopus oocytes described L-theanine as a partial co-agonist with excitatory action at NMDA receptors (Sebih et al., 2017), which is the opposite direction. Both are cell and tissue studies. Neither measured HPA-axis signaling, and neither has been replicated in humans.
Human EEG. The Evans 2021 trial used a 32-electrode montage and defined the alpha band as 8 to 12 Hz and theta as 4 to 7 Hz. Increased frontal and whole-scalp alpha power was observed at 3 hours post-dose in the eyes-open condition. No significant change in midline theta.
Manufacturing quality. Fermentation-derived from non-GMO corn-derived sucrose. Supplier specification ≥98% purity. Per the supplier, accepted into Australia’s Permissible Ingredients Determination in 2024 and produced in a facility the supplier describes as cGMP-compliant and ISO/FSSC-22000 certified. Supplier documentation available on request.
ATA Mg® Magnesium Acetyl Taurate (450 mg per capsule)
Molecular identity. Magnesium N-acetyltaurinate. Per the supplier’s technical dossier, N-acetylation of the amine moiety modifies the polarity of the taurate molecule, increasing lipophilicity and easing membrane passage. Treat this as a proposed mechanism; it has not been demonstrated in humans. N-acetyltaurine is an endogenous metabolite of taurine.
Magnesium’s role at NMDA channels. Magnesium produces a voltage-dependent block of glutamate-activated channels (Nowak et al., 1984), which is well established and independent of any particular magnesium form.
Pharmacokinetic evidence. Uysal et al. 2019 used direct tissue analysis in rats rather than serum proxies. Among five forms tested at a single oral dose, magnesium acetyl taurate achieved the highest brain tissue concentration, with magnesium malate following closely; malate had the highest AUC and acetyl taurate the second highest. Oxide and citrate showed the lowest bioavailability. Know the ceiling on this evidence: rodent data, seven animals per group, single dose, no human replication. There is no published human pharmacokinetic trial on magnesium acetyl taurate, which means every brain-delivery statement in this guide rests on animal data.
Regulatory. 2009 EFSA safety assessment of taurate magnesium sources, which is an assessment and not an EU authorization. NDIN #1139 on FDA’s public New Dietary Ingredient notification list, filed January 2020 by AIDP Inc. An NDI notification is a premarket safety notification, not approval.
Pyridoxal-5’-Phosphate (P-5-P, 2 mg per capsule)
Molecular mechanism. Active coenzyme form of vitamin B6. Forms a Schiff base with the glutamic acid decarboxylase (GAD) active site, the rate-limiting step converting glutamate to GABA. Unlike pyridoxine HCl, it requires no hepatic conversion. The Supplement Facts panel declares 2 mg of vitamin B6 as P-5-P, 118% of the Daily Value.
Upper limits. EFSA established a tolerable upper intake level of 12 mg per day for vitamin B6 in 2023, superseding its earlier figure. The U.S. National Institutes of Health lists a tolerable upper intake level of 100 mg per day for adults. The amount in this formula is well below both.
Magnesium and B6 evidence. Pouteau et al. (2018, PLOS ONE, n=264) found both magnesium plus B6 and magnesium alone reduced DASS-42 stress scores by roughly 42% to 45% over eight weeks with no significant difference between arms, concluding that adding B6 was not superior overall. In a pre-specified subgroup with severe or extremely severe stress (n=162), the combination showed 24% greater improvement at Week 8 (p=0.0203). That trial was single-blind (investigator-blinded) rather than double-blind, used 300 mg of magnesium per day, and used 30 mg of pyridoxine hydrochloride rather than P-5-P, in adults with low magnesemia. It supports the rationale for pairing the two nutrients; it does not validate this formula’s dose or form.
The Cortisol-Hippocampus Research Literature
The neurobiological basis is well established. Acute glucocorticoid exposure impairs hippocampal processes underlying episodic memory retrieval through several mechanisms, reviewed in detail by Gagnon and Wagner (Annals of the New York Academy of Sciences, 2016). The practical consequence, students blanking on material they demonstrably know, is the behavioral expression of those events during acute examination stress.
Whether L-theanine meaningfully intersects that pathway in humans is an open question. The Evans 2021 design, using objective cortisol assay and EEG during an active timed stressor, is the closest published analogue to exam conditions. It is a proxy. It is not an exam study, and the mechanistic link between reduced salivary cortisol and improved retrieval has not been demonstrated with this ingredient.
Safety and Interaction Guidance
In the Evans 2021 trial, no adverse events were classified as possibly related to the product, though one participant showed elevated AST and ALT liver enzymes between screening and day 8, which investigators classified as unlikely to be related. The four-week Hidese trial reported 100% compliance and no adverse events. The 2026 meta-analysis of 31 randomized trials assessed safety by comparing dropout rates and reasons and concluded L-theanine is safe.
Consult your healthcare provider before combining this or any supplement with a prescription medication, particularly anxiolytics, antidepressants, or ADHD medications. If you are under care for a diagnosed condition, discuss supplement use with your provider. Not for use if you are pregnant or nursing. Not intended for use by anyone under 18. Keep out of reach of children. This is a dietary supplement, not a substitute for academic accommodations if you have documented learning differences; consult your institution’s accessibility services.
Extended FAQ for Research-Literate Students
How much of this evidence actually applies to this specific product?
Less than most supplement pages would let you believe, which is why it’s worth stating precisely. One randomized controlled trial has been published on AlphaWave® L-Theanine at this dose. The 2026 meta-analysis covers L-theanine as an ingredient class across 31 trials and multiple branded sources. Hidese et al. 2019 used a different branded source. There is no human trial on magnesium acetyl taurate, no trial on 2 mg of P-5-P for stress or cognition, and no trial on the three ingredients together. The defensible position is a single-ingredient attention and stress claim on L-theanine at 200 mg; the magnesium and B6 layers are formulation rationale, not substantiated benefits.
Why do the two 2026-era meta-analyses disagree?
They pooled different trial sets and different outcomes. Gerolymos et al. (2026) pooled 31 randomized trials (n = 1,168) and found a significant acute improvement in choice reaction time. Mátyus et al. (2025) pooled five randomized trials (n = 148) and found a significant dose-dependent effect on rapid visual information processing and recognition visual reaction time, but no significant effect on simple reaction time or the Stroop test, concluding that the benefit could not be confirmed across all test methods. The most defensible reading is that L-theanine’s acute cognitive effect is real but domain-specific, and that the literature is small and heterogeneous enough that pooled estimates shift with inclusion criteria.
What effect sizes did the Hidese 2019 trial actually report?
The paper reports effect sizes as r values from Wilcoxon signed-rank and Mann-Whitney U tests, and the cognitive improvements were within-group. When changes were compared directly against placebo, no cognitive measure reached significance, except verbal and letter fluency in the lower-baseline subgroup (p=0.002, n=15). If you see a verbal fluency effect size of 0.61 quoted elsewhere, check the source. That figure appears in the paper as the effect size used in the a priori power calculation, carried over from the authors’ earlier work, not as a result of this trial.
Is the evidence base independent of the ingredient suppliers?
Largely not, and that’s a fair criticism. Evans et al. 2021 was funded by the supplier of AlphaWave® L-Theanine. Hidese et al. 2019 was funded by a different L-theanine supplier, with two co-authors employed there. Kimura et al. 2007 also included co-authors from that same second supplier, so it is not an independent replication either. The 2026 meta-analysis reports no specific funding, though its senior author declares having founded a dietary supplement company. Supplier funding does not invalidate a trial, but it belongs in your assessment.
Is there research specifically in student populations?
Not on this ingredient source. Existing student-population theanine research used different ingredient sources and higher daily intakes than this product’s one-capsule serving, so we don’t cite it as evidence for this formula. The broadest applicable evidence is the 2026 meta-analysis of 31 randomized trials, which found a single 200 mg dose taken 30 to 60 minutes before cognitive testing improved choice reaction time in healthy adults. Both human trials on branded L-theanine cited here enrolled general adult populations rather than students, and the four-week trial had a mean participant age of 48.3.*
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
The Evidence Is Published and Verifiable
You now know why blanking under exam pressure involves cortisol’s effect on memory retrieval, and roughly how far the research on L-theanine goes toward it.
L-Theanine Pro™ is a neuro-cofactor formula for students dealing with exam-day nerves and study cycles that work against sleep. One capsule daily.
Every study named here is published, peer-reviewed, and verifiable through the identifiers below before you spend a dollar. Read them yourself, limitations and all. We’ve put the limitations on this page precisely so you can check whether we’ve represented them fairly.
Understand the mechanism, then make an informed choice about what you take.
Shop the L-Theanine Pro™ 30-Count or 60-Count →
L-Theanine Pro may be a good fit when:
- You are a graduate or professional student who experiences consistent blanking despite thorough preparation
- Test-day nerves are creating a self-reinforcing loop where worry about blanking makes the stress response harder to settle
- You want a disclosed dose you can match against a specific published trial rather than a proprietary blend
- Difficulty settling before sleep is working against the memory consolidation that converts study sessions into retrievable knowledge
- You prefer an over-the-counter, non-controlled option and want the limitations stated plainly
L-Theanine Pro may not be the right fit when:
- Academic underperformance stems primarily from inadequate study time rather than test-day recall
- You are experiencing persistent anxiety or distress. That is a conversation for a licensed provider or your campus counseling service, not a supplement decision
- You require academic accommodations for documented learning differences. A supplement is not a substitute for institutional disability services
- You want proof that a supplement will raise your exam scores. No product has that evidence, including this one
Scientific References & Citations
All sources are independently verifiable through the DOI and, where the record is indexed, the PubMed identifier provided.
Human Clinical Trials and Meta-Analyses
Evans, M., McDonald, A. C., Xiong, L., Crowley, D. C., & Guthrie, N. (2021). A randomized, triple-blind, placebo-controlled, crossover study to investigate the efficacy of a single dose of AlphaWave® L-theanine on stress in a healthy adult population. Neurology and Therapy, 10(2), 1061–1078. https://doi.org/10.1007/s40120-021-00284-x (PMID: 34562208)
Gerolymos, C., Saddier, E., Boyer, L., & Fond, G. (2026). Cognitive and affective effects of L-theanine: A systematic review and meta-analysis of 31 randomized trials. Molecular Psychiatry. Advance online publication. https://doi.org/10.1038/s41380-026-03727-9 (PMID: 42410082)
Hidese, S., Ogawa, S., Ota, M., Ishida, I., Yasukawa, Z., Ozeki, M., & Kunugi, H. (2019). Effects of L-theanine administration on stress-related symptoms and cognitive functions in healthy adults: A randomized controlled trial. Nutrients, 11(10), 2362. https://doi.org/10.3390/nu11102362 (PMID: 31623400)
Kimura, K., Ozeki, M., Juneja, L. R., & Ohira, H. (2007). L-theanine reduces psychological and physiological stress responses. Biological Psychology, 74(1), 39–45. https://doi.org/10.1016/j.biopsycho.2006.06.006 (PMID: 16930802)
Mátyus, R. O., Szikora, Z., Bodó, D., Vargáné Szabó, B., Csupor, É., Csupor, D., & Tóth, B. (2025). Promising, but not completely conclusive: The effect of l-theanine on cognitive performance based on the systematic review and meta-analysis of randomized placebo-controlled clinical trials. Journal of Clinical Medicine, 14(21), 7710. https://doi.org/10.3390/jcm14217710 (PMID: 41227106)
Pouteau, E., Kabir-Ahmadi, M., Noah, L., Mazur, A., Dye, L., Hellhammer, J., Pickering, G., & Dubray, C. (2018). Superiority of magnesium and vitamin B6 over magnesium alone on severe stress in healthy adults with low magnesemia: A randomized, single-blind clinical trial. PLOS ONE, 13(12), e0208454. https://doi.org/10.1371/journal.pone.0208454 (PMID: 30562392)
Human Pharmacokinetics
van der Pijl, P. C., Chen, L., & Mulder, T. P. J. (2010). Human disposition of L-theanine in tea or aqueous solution. Journal of Functional Foods, 2(4), 239–244. https://doi.org/10.1016/j.jff.2010.08.001 (not indexed in PubMed)
Preclinical (Animal and Cell) Studies
Kakuda, T., Nozawa, A., Sugimoto, A., & Niino, H. (2002). Inhibition by theanine of binding of [³H]AMPA, [³H]kainate, and [³H]MDL 105,519 to glutamate receptors. Bioscience, Biotechnology, and Biochemistry, 66(12), 2683–2686. https://doi.org/10.1271/bbb.66.2683 (PMID: 12596867)
Nowak, L., Bregestovski, P., Ascher, P., Herbet, A., & Prochiantz, A. (1984). Magnesium gates glutamate-activated channels in mouse central neurones. Nature, 307(5950), 462–465. https://doi.org/10.1038/307462a0 (PMID: 6320006)
Sebih, F., Rousset, M., Bellahouel, S., Rolland, M., de Jesus Ferreira, M. C., Guiramand, J., Cohen-Solal, C., Barbanel, G., Cens, T., Abouazza, M., Tassou, A., Gratuze, M., Meusnier, C., Charnet, P., Vignes, M., & Rolland, V. (2017). Characterization of L-theanine excitatory actions on hippocampal neurons: Toward the generation of novel N-methyl-D-aspartate receptor modulators based on its backbone. ACS Chemical Neuroscience, 8(8), 1724–1734. https://doi.org/10.1021/acschemneuro.7b00036 (PMID: 28511005)
Uysal, N., Kizildag, S., Yuce, Z., Guvendi, G., Kandis, S., Koc, B., Karakilic, A., Camsari, U. M., & Ates, M. (2019). Timeline (bioavailability) of magnesium compounds in hours: Which magnesium compound works best? Biological Trace Element Research, 187(1), 128–136. https://doi.org/10.1007/s12011-018-1351-9 (PMID: 29679349)
Background and Mechanism Reviews
Gagnon, S. A., & Wagner, A. D. (2016). Acute stress and episodic memory retrieval: Neurobiological mechanisms and behavioral consequences. Annals of the New York Academy of Sciences, 1369(1), 55–75. https://doi.org/10.1111/nyas.12996 (PMID: 26799371)
Context on Student Stimulant Use
Arria, A. M., Wilcox, H. C., Caldeira, K. M., Vincent, K. B., Garnier-Dykstra, L. M., & O’Grady, K. E. (2017). Do college students improve their grades by using prescription stimulants nonmedically? Addictive Behaviors, 65, 245–249. https://doi.org/10.1016/j.addbeh.2016.07.016 (PMID: 27469455)
Edinoff, A. N., Nix, C. A., McNeil, S. E., Wagner, S. E., Johnson, C. A., Williams, B. C., Cornett, E. M., Murnane, K. S., Kaye, A. M., & Kaye, A. D. (2022). Prescription stimulants in college and medical students: A narrative review of misuse, cognitive impact, and adverse effects. Psychiatry International, 3(3), 221–235. https://doi.org/10.3390/psychiatryint3030018 (not indexed in PubMed)
Regulatory and Reference Sources
European Food Safety Authority. (2009). Iron (II) taurate, magnesium taurate and magnesium acetyl taurate as sources of iron or magnesium added for nutritional purposes to food supplements. EFSA Journal, 7(4), 947. https://doi.org/10.2903/j.efsa.2009.947
European Food Safety Authority Panel on Nutrition, Novel Foods and Food Allergens. (2023). Scientific opinion on the tolerable upper intake level for vitamin B6. EFSA Journal, 21(5), e08006. https://doi.org/10.2903/j.efsa.2023.8006
National Institutes of Health, Office of Dietary Supplements. (2025). Vitamin B6: Fact sheet for health professionals. U.S. Department of Health and Human Services. https://ods.od.nih.gov/factsheets/VitaminB6-HealthProfessional/
Therapeutic Goods Administration. (2024). Therapeutic Goods (Permissible Ingredients) Determination. Australian Government Department of Health and Aged Care. https://www.tga.gov.au/products/regulations-all-products/ingredients-and-scheduling-medicines-and-chemicals/permissible-ingredients-determination
U.S. Food and Drug Administration. (n.d.). GRAS notice inventory: GRN 209, GRN 338, GRN 501 (L-theanine). https://www.cfsanappsexternal.fda.gov/scripts/fdcc/index.cfm?set=GRASNotices&id=209
U.S. Food and Drug Administration. (2020). New dietary ingredient notification #1139: Magnesium acetyl taurinate (ATA-Mg®). https://www.fda.gov/media/160660/download
Evidence summary, stated plainly: One published randomized controlled trial on AlphaWave® L-Theanine at the 200 mg dose used here. One 2026 systematic review and meta-analysis of 31 randomized trials on L-theanine as an ingredient class at the same dose and timing, plus a smaller meta-analysis of five trials that found the acute cognitive effect to be domain-specific. Two additional human trials on different branded L-theanine sources. One comparative rodent bioavailability study on the magnesium form, with no human data. One human trial supporting magnesium and B6 pairing in a severe-stress subgroup, at a different dose and a different B6 form. No published trial has evaluated the complete L-Theanine Pro combination, tested magnesium acetyl taurate in humans, or measured exam performance.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.